Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022

Table of Contents

1 INTRODUCTION 15

1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.2.1 MARKETS COVERED 16
1.2.2 YEARS CONSIDERED FOR THE STUDY 16
1.3 CURRENCY 17
1.4 LIMITATIONS 17
1.5 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18

2.1 SECONDARY DATA 19
2.1.1 KEY DATA FROM SECONDARY SOURCES 19
2.2 PRIMARY DATA 20
2.2.1 KEY DATA FROM PRIMARY SOURCES 21
2.3 MARKET SIZE ESTIMATION 22
2.3.1 BOTTOM-UP APPROACH 22
2.3.2 TOP-DOWN APPROACH 23
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.5 ASSUMPTIONS FOR THE STUDY 25

3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 30

4.1 CELL-BASED ASSAYS: MARKET OVERVIEW 30
4.2 GEOGRAPHIC ANALYSIS: CELL-BASED ASSAYS MARKET, BY END USER (2017) 31
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL-BASED ASSAYS MARKET 32
4.4 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017 VS. 2022 33

5 MARKET OVERVIEW 34

5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Rising incidence of chronic diseases 36
5.2.1.2 Growing availability of funds for research 37
5.2.1.3 Growing preference for cell-based assays 37
5.2.1.4 Increasing drug discovery activity 38
5.2.2 RESTRAINT 38
5.2.2.1 High cost of instruments, restrictions on reagent use 38 
5.2.3 OPPORTUNITY 39
5.2.3.1 Asian countries 39

6 CELL-BASED ASSAYS MARKET, BY PRODUCT AND SERVICE 40

6.1 INTRODUCTION 41
6.2 CONSUMABLES 42
6.2.1 REAGENTS 43
6.2.2 ASSAY KITS 44
6.2.2.1 Reporter gene assays 45
6.2.2.2 Cell growth assays 46
6.2.2.3 Second messenger assays 47
6.2.2.4 Cell death assays 48
6.2.2.5 Other assays 49
6.2.3 MICROPLATES 50
6.2.4 CELL LINES 51
6.2.4.1 Immortalized cell lines 52
6.2.4.2 Primary cell lines 53
6.2.4.3 Stem cell lines 54
6.2.5 PROBES AND LABELS 55
6.2.6 OTHER CONSUMABLES 56
6.3 INSTRUMENTS 57
6.4 SERVICES 58
6.5 SOFTWARE 59

7 CELL-BASED ASSAYS MARKET, BY APPLICATION 60

7.1 INTRODUCTION 61
7.2 DRUG DISCOVERY 62
7.3 BASIC RESEARCH 63
7.4 ADME STUDIES 64
7.5 PREDICTIVE TOXICOLOGY 65
7.6 OTHER APPLICATIONS 66

8 CELL-BASED ASSAYS MARKET, BY END USER 67

8.1 INTRODUCTION 68
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 70
8.3 ACADEMIC & GOVERNMENT INSTITUTIONS 71
8.4 CONTRACT RESEARCH ORGANIZATIONS 72
8.5 OTHER END USERS 73
 

9 CELL-BASED ASSAYS MARKET, BY REGION 74

9.1 INTRODUCTION 75
9.2 NORTH AMERICA 77
9.2.1 U.S. 81
9.2.2 CANADA 84
9.3 EUROPE 86
9.3.1 GERMANY 89
9.3.2 FRANCE 92
9.3.3 U.K. 94
9.3.4 ITALY 96
9.3.5 SPAIN 98
9.3.6 ROE 100
9.4 ASIA 103
9.4.1 CHINA 107
9.4.2 JAPAN 109
9.4.3 INDIA 112
9.4.4 REST OF ASIA 114
9.5 REST OF THE WORLD 117

10 COMPETITIVE LANDSCAPE 120

10.1 INTRODUCTION 120
10.2 MARKET SHARE ANALYSIS 120
10.3 VENDOR DIVE OVERVIEW 121
10.3.1 VISIONARY LEADERS 121
10.3.2 INNOVATORS 121
10.3.3 DYNAMIC DIFFERENTIATORS 121
10.3.4 EMERGING COMPANIES 122
10.4 COMPETITIVE BENCHMARKING 123
10.4.1 BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE CELL-BASED ASSAYS MARKET (25 PLAYERS) 123
10.4.2 ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE CELL-BASED ASSAYS MARKET (25 PLAYERS) 124
*Top 25 companies analysed for this study are - Becton, Dickinson and Company. (U.S.), Cell Signaling Technology (U.S.), Danahar Corporation (U.S.), Cisbio Bioassays (France), Merck KGaA (Germany), GE Healthcare (U.K), DiscoverX Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), ProQinase GmbH (Germany), Charles River Laboratories International, Inc. (U.S.), Marine Biological Laboratory (U.S.), Biospherix, Ltd. (U.S.), Essen BioScience (U.S.), Miltenyi Biotec (Switzerland), BioAgilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Lonza (Switzerland), Aurelia Bioscience Ltd. (U.K), Selexis SA (U.S.), Life Technologies Corporation (U.S.), Cell Biolabs, Inc. (U.S.), BioTek Instruments, Inc. (U.S.), QGel SA (Switzerland)
 

11 COMPANY PROFILES 125

(Overview, Products and Services, Financials, Strategy & Development)*
11.1 BECTON, DICKINSON AND COMPANY 125
11.2 DANAHER CORPORATION 128
11.3 THERMO FISHER SCIENTIFIC INC. 131
11.4 GENERAL ELECTRIC COMPANY 134
11.5 MERCK KGAA 137
11.6 PERKINELMER, INC. 140
11.7 CHARLES RIVER LABORATORIES, INC. 142
11.8 LONZA GROUP LTD. 144
11.9 CELL SIGNALING TECHNOLOGY, INC. 147
11.10 PROMEGA CORPORATION 149
11.11 CISBIO BIOASSAYS 151
11.12 CELL BIOLABS, INC. 153
11.13 DISCOVERX CORPORATION 155
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
12 APPENDIX 157

LIST OF TABLES

TABLE 1 INCREASE IN CANCER PATIENT POPULATION, BY CANCER TYPE 36
TABLE 2 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 41
TABLE 3 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE,
2015–2022 (USD MILLION) 42
TABLE 4 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY REGION,
2015–2022 (USD MILLION) 42
TABLE 5 CELL-BASED ASSAYS MARKET FOR REAGENTS, BY REGION,
2015–2022 (USD MILLION) 43
TABLE 6 CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE,
2015–2022 (USD MILLION) 44
TABLE 7 CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY REGION,
2015–2022 (USD MILLION) 45
TABLE 8 CELL-BASED ASSAYS MARKET FOR REPORTER GENE ASSAYS, BY REGION,
2015–2022 (USD MILLION) 45
TABLE 9 CELL-BASED ASSAYS MARKET FOR CELL GROWTH ASSAYS, BY REGION,
2015–2022 (USD MILLION) 46
TABLE 10 CELL-BASED ASSAYS MARKET FOR SECOND MESSENGER ASSAYS, BY REGION, 2015–2022 (USD MILLION) 47
TABLE 11 CELL-BASED ASSAYS MARKET FOR CELL DEATH ASSAYS, BY REGION,
2015–2022 (USD MILLION) 48
TABLE 12 OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2015–2022 (USD MILLION) 49
TABLE 13 CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY REGION,
2015–2022 (USD MILLION) 50
TABLE 14 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 15 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE,
2015–2022 (USD MILLION) 51
TABLE 16 CELL-BASED ASSAYS MARKET FOR IMMORTALIZED CELL LINES, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 17 CELL-BASED ASSAYS MARKET FOR PRIMARY CELL LINES, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 18 CELL-BASED ASSAYS MARKET FOR STEM CELL LINES, BY REGION,
2015–2022 (USD MILLION) 54
TABLE 19 CELL-BASED ASSAYS MARKET FOR PROBES AND LABELS, BY REGION,
2015–2022 (USD MILLION) 55
TABLE 20 CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY REGION,
2015–2022 (USD MILLION) 56
TABLE 21 CELL-BASED ASSAYS MARKET FOR INSTRUMENTS, BY REGION,
2015–2022 (USD MILLION) 57
TABLE 22 CELL-BASED ASSAYS MARKET FOR SERVICES, BY REGION,
2015–2022 (USD MILLION) 58
TABLE 23 CELL-BASED ASSAYS MARKET FOR SOFTWARE, BY REGION,
2015–2022 (USD MILLION) 59 
TABLE 24 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 61
TABLE 25 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY REGION,
2015–2022 (USD MILLION) 62
TABLE 26 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION,
2015–2022 (USD MILLION) 63
TABLE 27 CELL-BASED ASSAYS MARKET FOR ADME STUDIES, BY REGION,
2015–2022 (USD MILLION) 64
TABLE 28 CELL-BASED ASSAYS MARKET FOR PREDICTIVE TOXICOLOGY, BY REGION,
2015–2022 (USD MILLION) 65
TABLE 29 OTHER CELL-BASED ASSAY APPLICATIONS MARKET, BY REGION,
2015–2022 (USD MILLION) 66
TABLE 30 CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2015–2022 (USD MILLION) 69
TABLE 31 CELL-BASED ASSAYS MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION) 70
TABLE 32 CELL-BASED ASSAYS MARKET SIZE FOR ACADEMIC & GOVERNMENT INSTITUTIONS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 33 CELL-BASED ASSAYS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015–2022 (USD MILLION) 72
TABLE 34 CELL-BASED ASSAYS MARKET SIZE FOR OTHER END USERS, BY REGION,
2015–2022 (USD MILLION) 73
TABLE 35 CELL-BASED ASSAYS MARKET, BY REGION, 2015–2022 (USD MILLION) 76
TABLE 36 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 79
TABLE 37 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION) 79
TABLE 38 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 80
TABLE 39 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER,
2015–2022 (USD MILLION) 81
TABLE 40 U.S.: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 82
TABLE 41 U.S.: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 83
TABLE 42 U.S.: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 83
TABLE 43 CANADA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 84
TABLE 44 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 85
TABLE 45 CANADA: CELL-BASED ASSAYS MARKET, BY END USER,
2015–2022 (USD MILLION) 86
TABLE 46 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 87
TABLE 47 EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 87
TABLE 48 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 88
TABLE 49 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER,
2015–2022 (USD MILLION) 89
TABLE 50 GERMANY: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 90
TABLE 51 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 91
TABLE 52 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER,
2015–2022 (USD MILLION) 91
TABLE 53 FRANCE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 93
TABLE 54 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 93
TABLE 55 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER,
2015–2022 (USD MILLION) 94
TABLE 56 U.K.: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 95
TABLE 57 U.K.: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 95
TABLE 58 U.K.: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 96
TABLE 59 ITALY: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 96
TABLE 60 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 97
TABLE 61 ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 98
TABLE 62 SPAIN: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 98
TABLE 63 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 99
TABLE 64 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 100
TABLE 65 ROE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 101
TABLE 66 ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 101
TABLE 67 ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 102
TABLE 68 ASIA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 105
TABLE 69 ASIA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 106
TABLE 70 ASIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 106
TABLE 71 ASIA: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 107
TABLE 72 CHINA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 107
TABLE 73 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 108
TABLE 74 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 109
TABLE 75 JAPAN: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 110
TABLE 76 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 111
TABLE 77 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 111
TABLE 78 INDIA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 112
TABLE 79 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 113
TABLE 80 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 114
TABLE 81 ROA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 114
TABLE 82 ROA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 115
TABLE 83 ROA: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 116
TABLE 84 ROW: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE,
2015–2022 (USD MILLION) 118
TABLE 85 ROW: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 118
TABLE 86 ROW: CELL-BASED ASSAYS MARKET, BY END USER, 2015–2022 (USD MILLION) 119
 

LIST OF FIGURES

FIGURE 1 GLOBAL CELL-BASED ASSAYS MARKET 16
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 20
FIGURE 4 CELL-BASED ASSAYS MARKET: BOTTOM-UP APPROACH 22
FIGURE 5 CELL-BASED ASSAYS MARKET: TOP-DOWN APPROACH 23
FIGURE 6 DATA TRIANGULATION METHODOLOGY 24
FIGURE 7 GLOBAL CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017 VS. 2022 (USD BILLION) 26
FIGURE 8 GLOBAL CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017 VS. 2022 (USD BILLION) 27
FIGURE 9 GLOBAL CELL-BASED ASSAYS MARKET, BY END USER,
2017 VS. 2022 (USD BILLION) 28
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE GLOBAL CELL-BASED ASSAYS MARKET 29
FIGURE 11 GLOBAL CELL-BASED ASSAYS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD 30
FIGURE 12 PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CELL-BASED ASSAYS MARKET IN 2017 31
FIGURE 13 ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 32
FIGURE 14 DRUG DISCOVERY SEGMENT WILL CONTINUE TO DOMINATE THE CELL-BASED ASSAYS MARKET IN 2022 33
FIGURE 15 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINT, AND OPPORTUNITIE 35
FIGURE 16 CONSUMABLES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING
2017–2022 41
FIGURE 17 DRUG DISCOVERY WILL CONTINUE TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD 61
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD 68
FIGURE 19 ASIAN CELL-BASED ASSAYS MARKET TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 75
FIGURE 20 ASIAN CELL-BASED ASSAYS MARKET TO REGISTER THE HIGHER CAGR DURING FORECAST PERIOD 76
FIGURE 21 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT 78
FIGURE 22 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN NORTH AMERICA 80
FIGURE 23 CONSUMABLES, THE LARGEST SEGMENT IN THE U.S. CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, IN 2017 82
FIGURE 24 DRUG DISCOVERY APPLICATION SEGMENT TO DOMINATE THE CANADIAN MARKET IN 2017 85
FIGURE 25 CONTRACT RESEARCH ORGANIZATIONS, THE FASTEST-GROWING END-USER SEGMENT IN EUROPE 88
FIGURE 26 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT & SERVICE SEGMENT IN THE GERMAN CELL-BASED ASSAYS MARKET IN 2017 90
FIGURE 27 DRUG DISCOVERY TO DOMINATE THE FRENCH CELL-BASED ASSAYS MARKET,
BY APPLICATION, IN 2017 92
FIGURE 28 CONSUMABLES, THE LARGEST PRODUCT & SERVICE SEGMENT IN THE U.K. MARKET IN 2017 94
FIGURE 29 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE
THE LARGEST END-USER SEGMENT IN THE ITALIAN MARKET, 2017 97
FIGURE 30 DRUG DISCOVERY, THE LARGEST APPLICATION SEGMENT IN THE SPANISH MARKET IN 2017 99
FIGURE 31 ROE MARKET, BY END USER: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ESTIMATED TO HOLD LARGEST SHARE IN 2017 102
FIGURE 32 ASIA: CELL-BASED ASSAYS MARKET SNAPSHOT 104
FIGURE 33 CONSUMABLES TO ACCOUNT FOR THE LARGEST PRODUCT SEGMENT OF THE CELL-BASED ASSAYS MARKET IN ASIA IN 2017 105
FIGURE 34 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST END-USER SEGMENT OF THE MARKET IN CHINA IN 2017 108
FIGURE 35 CONSUMABLES TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, IN JAPAN, 2017 110
FIGURE 36 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST APPLICATION OF
THE CELL-BASED ASSAYS MARKET IN INDIA IN 2017 113
FIGURE 37 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST END-USER OF THE CELL-BASED ASSAYS MARKET IN ROA IN 2017 115
FIGURE 38 CONSUMABLES TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET IN ROW IN 2017 117
FIGURE 39 GLOBAL CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016 120
FIGURE 40 DIVE CHART 122
FIGURE 41 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016) 125
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2016) 128
FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016) 131
FIGURE 44 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2016) 134
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2016) 137
FIGURE 46 PERKINELMER, INC.: COMPANY SNAPSHOT (2017) 140
FIGURE 47 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2016) 142
FIGURE 48 LONZA GROUP LTD.: COMPANY SNAPSHOT (2016) 144

当レポートのプレスリリースは発行されておりません。